Clinical Trials Logo

Sepsis clinical trials

View clinical trials related to Sepsis.

Filter by:

NCT ID: NCT03644940 Withdrawn - Sepsis Clinical Trials

Subpopulation-Specific Sepsis Identification Using Machine Learning

Start date: December 2020
Phase: Phase 2
Study type: Interventional

The focus of this study will be to conduct a prospective, randomized controlled trial (RCT) at Cape Regional Medical Center (CRMC), Oroville Hospital (OH), and UCSF Medical Center (UCSF) in which a subpopulation-optimized algorithm will be applied to EHR data for the detection of severe sepsis. For patients determined to have a high risk of severe sepsis, the algorithm will generate automated voice, telephone notification to nursing staff at CRMC, OH, and UCSF. The algorithm's performance will be measured by analysis of the primary endpoint, in-hospital SIRS-based mortality. The secondary endpoints will be in-hospital severe sepsis/shock-coded mortality, SIRS-based hospital length of stay, and severe sepsis/shock-coded hospital length of stay.

NCT ID: NCT03517501 Withdrawn - Clinical trials for Sepsis and Coagulopathy

The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy

Scarlet2
Start date: July 2019
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate if ART-123 given to patients who have severe sepsis can decrease mortality.

NCT ID: NCT03488940 Withdrawn - Sepsis Clinical Trials

Effect of Different Feeding Method on Gastrointestinal Function of Septic Patients (DFM-GF Trial)

DFM-GF
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The intestine is the most vulnerable target organ in septic patients and is the first to be damaged organ in multiple organ dysfunction syndrome(MODS). Therefore, improving intestinal motility and mucosal barrier function is critical to the treatment of sepsis. Many studies have shown that, early enteral nutrition(EN) in patients with sepsis helps prevent and treat intestinal dysfunction, reducing ICU mortality and length of stay in ICU. However, there is little research on feeding methods. In this study we will compare the outcomes of different feeding methods: continuously-pumped in 24 hours, continuously-pumped in 16 hours and intermittently-pumped through the stomach tube. The aim of this study is to investigate the effects of different feeding methods on intestinal function in septic patients.

NCT ID: NCT03282292 Withdrawn - Clinical trials for Congenital Heart Disease

Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery

PRECiSE
Start date: September 12, 2017
Phase: N/A
Study type: Interventional

Randomized controlled trial comparing femoral vs internal jugular insertion site of central venous catheters (CVC) in newborns and infants undergoing cardiac surgery. The experimental hypothesis is that the jugular insertion site is superior to the femoral in terms of catheter colonization.

NCT ID: NCT03167788 Withdrawn - Sepsis Clinical Trials

Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery

Start date: December 2020
Phase: Phase 2
Study type: Interventional

The REDJUVENATE Trial proposes to test the hypothesis that postoperative organ injury and inflammation will be less if patients undergoing cardiac surgery who are at risk of large volume blood transfusion (defined as the administration of ≥4 units of red cells) receive rejuvenated washed cells compared to standard care (unwashed aged stored cells).

NCT ID: NCT03090919 Withdrawn - Sepsis Clinical Trials

The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis

INFUSE
Start date: January 3, 2017
Phase: N/A
Study type: Interventional

Sepsis is life-threatening and dysregulated response to infection that results in endothelial activation and dysfunction that leads to systemic microvascular leak and multiple-organ failure. This study will identify patients that have sepsis with thrombocytopenia and randomize them to receive a unit of platelets or an equivalent volume of saline.

NCT ID: NCT02929160 Withdrawn - Sepsis Clinical Trials

Percutaneous Nephrostomy Versus Stent In Sepsis Trial

PERSIST
Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Randomized control trial to compare the efficacy and safety of percutaneous nephrostomy with retrograde ureteric stenting for emergency renal decompression in cases of obstruction and sepsis associated with ureteric calculi.

NCT ID: NCT02886910 Withdrawn - Chorioamnionitis Clinical Trials

Chorioamnionitis: Observation of at Risk Infants vs Standard Care

CHORIS-RCT
Start date: October 2016
Phase: N/A
Study type: Interventional

This study evaluates the non-inferiority of a protocol of limited evaluation (complete blood count, blood culture) and clinical observation by standardized physical examination versus the algorithm suggested in the CDC's 2010 guidelines (limited evaluation, clinical observation and antibiotic therapy) in the management of asymptomatic infants born at term to mothers with suspected chorioamnionitis. The primary outcome of the study is the difference in the prevalence of sepsis-related symptoms between the two groups.

NCT ID: NCT02885688 Withdrawn - Septic Shock Clinical Trials

Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe Sepsis

Start date: October 2016
Phase: Phase 2
Study type: Interventional

The goal of this clinical research study is to learn if adding liquid nutrition therapy that is given by vein to standard-of-care treatment for sepsis can help to control sepsis symptoms better than giving standard-of-care treatment alone. Researchers also want to compare the length of ICU and hospital stay and any side effects between these 2 treatments.

NCT ID: NCT02771158 Withdrawn - Sepsis Clinical Trials

Midodrine During Recovery From Septic Shock

Start date: August 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether midodrine administration decreases duration of intravenous vasopressors and intensive care unit length of stay for patients in septic shock.